Canada Markets closed

Cytosorbents Corporation (CTSO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
8.73+0.38 (+4.55%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close8.35
Open8.41
Bid8.63 x 1100
Ask8.81 x 1000
Day's Range8.35 - 8.86
52 Week Range6.99 - 11.68
Volume469,335
Avg. Volume293,535
Market Cap378.177M
Beta (5Y Monthly)0.27
PE Ratio (TTM)N/A
EPS (TTM)-0.21
Earnings DateMay 04, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est14.60
  • Simply Wall St.

    A Look At The Intrinsic Value Of Cytosorbents Corporation (NASDAQ:CTSO)

    In this article we are going to estimate the intrinsic value of Cytosorbents Corporation ( NASDAQ:CTSO ) by estimating...

  • Simply Wall St.

    Could The Cytosorbents Corporation (NASDAQ:CTSO) Ownership Structure Tell Us Something Useful?

    Every investor in Cytosorbents Corporation ( NASDAQ:CTSO ) should be aware of the most powerful shareholder groups...

  • Motley Fool

    Here's Why Cytosorbents Is Up 17% Today

    Shares of Cytosorbents Corporation (NASDAQ: CTSO) jumped 17.3% on Tuesday, spurred higher by news that the Investigational Device Exemption (IDE) request for its DrugSorb-ATR Antithrombotic Removal system has been approved by the U.S. Food and Drug Administration, allowing clinical trials of the device to move forward. Cytosorbents' DrugSorb-ATR Antithrombotic Removal device just cleared another regulatory hurdle. Exempt from certain other steps that some medical devices must go through, the company can now begin testing the device, which allows patients undergoing heart bypass surgeries to curb the amount of blood-thinning drug ticagrelor in the bloodstream during and after the procedure.